Structural aspects of HLA class I epitopes reacting with human monoclonal antibodies in Ig-binding, C1q-binding and lymphocytotoxicity assays

Human Immunology

Volumn 74, Issue 10, 2013, Pages 1271-1279

  Duquesnoy, Rene J ^a   Marrari, Marilyn ^a   Jelenik, Larry ^a   Zeevi, Adriana ^a   Claas, Frans H J ^b   Mulder, Arend ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; COMPLEMENT COMPONENT C1Q; COMPLEMENT FIXING ANTIBODY; EPITOPE; HLA ANTIGEN CLASS 1; HUMAN MONOCLONAL ANTIBODY; IMMUNOGLOBULIN;

ALLELE; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ARTICLE; BINDING SITE; COMPLEMENT ACTIVATION; COMPLEMENTARITY DETERMINING REGION; CONFORMATIONAL TRANSITION; ENERGY; HUMAN; IMMUNOREACTIVITY; LYMPHOCYTOTOXICITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE;

AMINO ACIDS; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY COMPLEX; COMPLEMENT C1Q; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN CONFORMATION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84883789001     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.05.016     Document Type: Article

References (49)

1. Colvin R. Dimensions of antibody-mediated rejection. Am J Transplant 2010, 10:1509-1510.
2. Jordan S.C. Complement fixing donor-specific antibodies and allograft loss. Pediatr Transplant 2012, 16:1-3.
3. Pei R., Lee J.H., Shih N.J., Chen M., Terasaki P.I. Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation 2003, 75(1):43-49.
4. Chen G., Sequeira F., Tyan D.B. Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads. Hum Immunol 2011, 72(10):849-858.
5. Chin C., Chen G., Sequeria F., Berry G., Siehr S., Bernstein D., et al. Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients. J Heart Lung Transplant 2011, 30(2):158-163.
6. Sutherland S.M., Chen G., Sequeira F.A., Lou C.D., Alexander S.R., Tyan D.B. Complement-fixing donor-specific antibodies identified by a novel C1q assay are associated with allograft loss. Pediatr Transplant 2012, 16(1):12-17.
7. Yabu J.M., Higgins J.P., Chen G., Sequeira F., Busque S., Tyan D.B. C1q-fixing human leukocyte antigen antibodies are specific for predicting transplant glomerulopathy and late graft failure after kidney transplantation. Transplantation 2011, 91(3):342-347.
8. Tyan D.B. New approaches for detecting complement-fixing antibodies. Curr Opin Organ Transplant 2012, 17:409-415.
9. Zeevi A., Marrari M., Feingold B., Webber S., Duquesnoy R. Human leukocyte antigen epitope analysis to assess complement- and noncomplement-binding donor-specific antibody repertoire in a pediatric heart transplant recipient. Hum Immunol 2012, 73:48-51.
10. Duquesnoy R. Clinical usefulness of HLAMatchmaker in HLA epitope matching for organ transplantation. Curr Opin Immunol 2008, 20:594-601.
11. Duquesnoy R.J., Marrari M. HLAMatchmaker-based definition of structural HLA epitopes detected by alloantibodies. Curr Opin Transplant 2009, 14:403-409.
12. Duquesnoy R.J. A structurally based approach to determine HLA compatibility at the humoral immune level. Hum Immunol 2006, 67:847-862.
13. Duquesnoy R.J., Mulder A., Askar M., Fernandez-Vina M., Claas F.H.J. HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes. Hum Immunol 2005, 66:749-761.
14. Marrari M., Mostecki J., Mulder A., Balazs I., Claas F., Duquesnoy R. Human monoclonal antibody reactivity with HLA Class I epitopes defined by pairs of mismatched eplets and self eplets. Transplantation 2010, 90:1468-1472.
15. Duquesnoy R.J., Schindler T.E. Serological analysis of the HLA-A10 complex. Tissue Antigens 1976, 72:65-73.
16. Hackbarth SA, Duquesnoy RJ Serologic analysis of the HLA-A10 complex II. absorption studies on Aw25, Aw26 and Aw34. Transplant P 1977, 9(Suppl. 1):43-45.
17. Duquesnoy R.J. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. ASHI Q 2002, 60-62.
18. Mulder A., Kardol M., Blom J., Jolley W., Melief C., Bruning H. A human monoclonal antibody, produced following in vitro immunization, recognizing an epitope shared by HLA-A2 subtypes and HLA-A28. Tissue Antigens 1993, 42:27-34.
19. Mulder A, Kardol M, Niterink J, Parlevliet J, Marrari M, Tanke J. Successful strategy for the large scale development of HLA-specific human monoclonal antibodies.12th International histocompatibility workshop; 1996; Paris: EDR Publishers, Paris, France.
20. Mulder A., Kardol M., Regan J., Buelow R., Claas F. Reactivity of twenty-two cytotoxic human monoclonal HLA antibodies towards soluble HLA class I in an enzyme-linked immunosorbent assay (PRA-STAT). Hum Immunol 1997, 56:106-113.
21. Fernandez-Vina M, Maiers M, Gutierrez M, Mulder A, Lee JH, Stoddard J, et al., editors. 13th IHWS serology and HLA phenotypes joint report.Specificities of the reagents utilized in the serology component of the 13th IHWS. Immunobiology of the human MHC 13th international histocompatibility workshop and conference; 2002.
22. Hogue C. Cn3D: a new generation of three-dimensional molecular structure viewer. Trends Biochem Sci 1997, 22:314-316.
23. *0702 characterizes multiple distinct epitopes for anti-HLA antibodies. Hum Immunol 1992, 35(2):125-131.
24. Kushihata F., Watanabe J., Mulder A., Claas F., Scornik J. Human leukocyte antigen antibodies and human complement activation: role of IgG subclass, specificity, and cytotoxic potential. Transplantation 2004, 78:995-1001.
25. Watanabe J., Scornik J.C. Measuring human complement activation by HLA antibodies. Arch Pathol Lab Med 2006, 130:368-373.
26. AlMahri A., Holgerson J., Alheim M. Detection of complement-fixing and non-fixing antibodies specific for endothelial precursor cells and lymphocytes using flow cytometry. Tissue Antigens 2012, 80:404-415.
27. Davies D., Padlan E., Sheriff S. Antibody-antigen complexes. Annu Rev Biochem 1990, 59:439-473.
28. Wilson I.A., Stanfield R.L. Antibody-antigen interactions: new structures and new conformational changes. Curr Opin Struct Biol 1994, 4:857-867.
29. Padlan E.A. Anatomy of the antibody molecule. Mol Immunol 1994, 31:169-217.
30. MacCallum R.M., Martin A.C.R., Thornton J.M. Antibody-Antigen interactions: contact analysis and binding site topography. J Mol Biol 1996, 262:732-745.
31. Sundberg E.J., Mariuzza R.A. Molecular recognition in antibody-antigen complexes. Adv Protein Chem 2002, 61:119-160.
32. Sherman L., Chattopadhyay S., Biggs J., Dick R., Bluestone J. Alloantibodies can discriminate class I major histocompatibility complex molecules associated with various endogenous peptides. Proc Natl Acad Sci USA 1993, 90:6949-6951.
33. Porgador A., Yewdell J.W., Deng Y., Bennink J.R., Germain R.N. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 1997, 6:715-726.
34. Messaoudi I., LeMaoult J., Nikolic-Zugic J. The mode of ligand recognition by two peptide:MHC class I-specific monoclonal antibodies. J Immunol 1999, 163:3286-3294.
35. Urban R.G., Chicz R.M., Lane W.S., Strominger J.L., Rehm A., Kenter M.J., et al. A subset of HLA-B27 molecules contains peptides much longer than nonamers. Proc Natl Acad Sci USA 1994, 91:1534-1538.
36. Wang J., Yu D.T., Fukazawa T., Kellner H., Wen X.K., Cheng X.K., et al. A monoclonal antibody that recognizes HLA-B27 in the context of peptides. J Immunol 1994, 152:1197-1205.
37. Barouch D., Davenport M., McMichael A., Reay P. A mAb against HLA-A2 can be influenced both positively and negatively by the associated peptide. Int Immunol 1995, 7(10):1599-1605.
38. *5101 binding nonamer peptides in formation of the HLA-Bw4 public epitope. Int Immunol 1996, 8(7):1027-1034.
39. Sakaguchi T., Takamiya Y., Edidin M., Nokihara K., Miwa K., Schoenbach C., et al. Crucial role of N-terminal residue of binding peptides in recognition of the monoclonal antibody specific for the peptide-HLA-B5,-B35 complex. Immunogenetics 1998, 47:149-158.
40. Mulder M., Eijsink C., Kester M.G.D., Franke M.E.I., Kardol M.J., Heemskerk M.H.M., et al. Impact of peptides on the recognition of HLA class I molecules by human HLA antibodies. J Immunol 2005, 175:5950-5957.
41. Duquesnoy R. The antibody response to an HLA mismatch: a model for nonself-self discrimination in relation to HLA epitope immunogenicity. Int J Immunogenet 2011, 39:1-9.
42. Duquesnoy R. Humoral alloimmunity in transplantation: relevance of HLA epitope antigenicity and immunogenicity. Front Transplant Alloimmunity 2011, 2:59. (published online).
43. Duquesnoy R., Marrari M., Mulder A., Claas F., Mostecki J., Balazs I. Structural aspects of HLA class I epitopes detected by human monoclonal antibodies. Hum Immunol 2012, 73:267-277.
44. Marrari M., Conca R., Praticò-Barbato L., Amoroso A., Duquesnoy R. Brief report: why did two patients who type for HLA-B13 have antibodies that react with all Bw4 antigens except HLA-B13?. Transplant Immunol 2011, 25:217-220.
45. Eisen H.N., Siskind G.W. Variations in affinities of antibodies during the immune response. Biochemistry 1964, 3:996-1008.
46. Berek C., Milstein C. Mutation drift and repertoire shift in the maturation of the immunine response. Immunol Rev 1987, 96:23-41.
47. Foote J., Milstein C. Kinetic maturation of an immune response. Nature 1991, 352:530-532.
48. Makela O. J Immunol 1965, 95:378-386.
49. Chitarra V., Alzari P.M., Bentley G.A., Bhat T.N., Eisele J.L., Houdusse A., et al. Three-dimensional structure of a heteroclitic antigen-antibody cross-reaction complex. Proc Natl Acad Sci USA 1993, 90:7711-7715.